Incyte (INCY) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 221.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.87% |
| Dec 31, 2025 | 5,913.92% |
| Sep 30, 2025 | -95.91% |
| Jun 30, 2025 | 110.31% |
| Mar 31, 2025 | 727.42% |
| Dec 31, 2024 | -102.90% |
| Sep 30, 2024 | 114.24% |
| Jun 30, 2024 | -94.32% |
| Mar 31, 2024 | -96.78% |
| Dec 31, 2023 | 161.20% |
| Sep 30, 2023 | -169.15% |
| Jun 30, 2023 | -43.50% |
| Mar 31, 2023 | -24.47% |
| Dec 31, 2022 | 55.57% |
| Sep 30, 2022 | -13.50% |
| Jun 30, 2022 | -86.06% |
| Mar 31, 2022 | -25.86% |
| Dec 31, 2021 | -1,297.92% |
| Sep 30, 2021 | 1,723.07% |
| Jun 30, 2021 | 480.92% |
| Mar 31, 2021 | -45.85% |
| Dec 31, 2020 | 127.68% |
| Sep 30, 2020 | 88.22% |
| Jun 30, 2020 | -151.69% |
| Mar 31, 2020 | 114.95% |
| Dec 31, 2019 | 11.13% |
| Sep 30, 2019 | -167.73% |
| Jun 30, 2019 | 338.27% |
| Mar 31, 2019 | 45.09% |
| Dec 31, 2018 | -140.43% |
| Sep 30, 2018 | 161.00% |
| Jun 30, 2018 | -64.62% |
| Mar 31, 2018 | -39.95% |
| Dec 31, 2017 | 2,406.18% |
| Sep 30, 2017 | 49.63% |
| Jun 30, 2017 | -62.90% |
| Mar 31, 2017 | 276.97% |
| Dec 31, 2016 | -42.00% |
| Sep 30, 2016 | -704.78% |
| Jun 30, 2016 | 3,643.81% |
| Mar 31, 2016 | 56.54% |
| Dec 31, 2015 | 549.95% |
| Sep 30, 2015 | -13.56% |
| Jun 30, 2015 | -74.76% |
| Mar 31, 2015 | 33.42% |
| Dec 31, 2014 | -93.77% |
| Sep 30, 2014 | 1,858.56% |
| Jun 30, 2014 | 1,473.06% |
| Mar 31, 2014 | 197.87% |
| Dec 31, 2013 | 1,732.04% |
| Sep 30, 2013 | 94.33% |
| Jun 30, 2013 | -45.08% |
| Mar 31, 2013 | 80.24% |
| Dec 31, 2012 | -6.25% |
| Sep 30, 2012 | -65.59% |
| Jun 30, 2012 | -6.33% |
| Mar 31, 2012 | -10.14% |
| Dec 31, 2011 | -63.78% |
| Sep 30, 2011 | 153.22% |
| Jun 30, 2011 | 79.77% |
| Mar 31, 2011 | 80.39% |